4808 Results

People

  1. Travis
    Travis
  2. Berger
    Berger
  3. Hudis
    Hudis
  4. Ladanyi
    Ladanyi
  5. Arcila
    Arcila
  6. Reis-Filho
    Reis-Filho
  7. Weigelt
    Weigelt
  8. Giralt
    Giralt
  9. Levine
    Levine
  10. Motzer
    Motzer

Groups

  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)
  7. Department of Pathology and Laboratory Medicine (714)
  8. Hematologic Malignancies, Division of (683)
  9. Population Sciences Research Program (601)
  10. Sloan Kettering Institute Faculty (586)
  1. "2015"
Formats
  1. Journal Article (2716)
  2. Meeting Abstract (1680)
  3. Book Section (364)
  4. Conference Paper (26)
  5. Book Whole (19)
  6. Review (2)
  7. Research Letter (1)
Groups
  1. Department of Medicine (1855)
  2. GSK Faculty (1116)
  3. Solid Tumor Oncology Division (1035)
  4. Surgery (883)
  5. Survivorship Research (752)
  6. Center for Hematologic Malignancies (746)

More Groups

People
  1. William Travis (102)
  2. Michael Berger (96)
  3. Clifford Hudis (85)
  4. Marc Ladanyi (79)
  5. Jedd Wolchok (68)
  6. Britta Weigelt (67)

More People

Years
  1. 2015 (4808)
Publications
  1. Journal of Clinical Oncology (475)
  2. Blood (224)
  3. Cancer Research (168)
  4. Modern Pathology (125)
  5. Laboratory Investigation (112)
  6. International Journal of Radiation Oncology, Biology, Physics (91)

More Publications

Publishers
  1. Elsevier Inc. (581)
  2. American Society of Clinical Oncology (508)
  3. Springer (380)
  4. Nature Publishing Group (301)
  5. American Association for Cancer Research (263)
  6. American Society of Hematology (228)

More Publishers

Results (4808)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Selective inhibitor of nuclear exporter CRM1/XPO1, Selinexor (KPT-330), exhibits remarkable activity against AML leukemia-initiating cells while sparing normal hematopoietic cells
    Meeting Abstract

    Etchin, J.; Le, B. T.; Berezovskaya, A.; Conway, A. S.; Chen, W. C.; Kentsis, A.; Mansour, M. R.; Stone, R. M.; Galinsky, I. A.; DeAngelo, D. J.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • A phase II trial of exemestane and ruxolitinib for aI-resistant ER plus breast cancer: Interim safety, efficacy, and biomarker analysis
    Meeting Abstract

    DeMichelel, A. M.; Colameco, C. B.; Kalota, A.; Troxel, A. B.; Holmes, R.; Cimildoro, R.; Zafman, K.; Fox, K. R.; Domchek, S. M.; Gogineni, K.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Targeting p53 mutant cancers through inhibition of the phosphatidylinositol-5-phosphate 4-kinases
    Meeting Abstract

    Emerling, B. M.; Yang, Z. W.; Loughran, R.; Yang, T. J.; Johnson, J.; Pragani, R.; Davis, M.; Shen, M.; Boxer, M.; Simeonov, A.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Strong MAGE-A3-specific humoral and cellular immune responses in multiple myeloma patients receiving MAGE-A3 protein immunotherapy and peripheral blood lymphocyte reconstitution
    Meeting Abstract

    Gnjatic, S.; Nataraj, S.; Imai, N.; Jungbluth, A. A.; Pan, L.; Venhaus, R.; Fellague-Chebra, R.; Gruselle, O.; Cohen, A.; Lendvai, N.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Next-generation sequencing enables new approach to molecular cytogenetics
    Meeting Abstract

    He, J.; Gardner, J.; Sun, J. X.; Abdel-Wahab, O.; Intlekofer, A. M.; Nahas, M. K.; Vergilio, J. A.; Ross, J. S.; Yelenskey, R.; Levine, R.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Genomic characterization of brain metastases reveals divergent evolution and metastasis specific mutations
    Meeting Abstract

    Brastianos, P. K.; Carter, S. L.; Santagata, S.; Taylor-Weiner, A.; Jones, R. T.; Van Allen, E.; Ligon, K. L.; Tabernero, J.; Seoane, J.; Martinez-Saez, E.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Inactivation of neogenin promotes castration resistance and bone metastasis in prostate cancer models
    Meeting Abstract

    Chakraborty, G.; Gadiya, M.; Kossai, M.; Gao, D.; Su, W. J.; Gao, H.; Chen, Y.; Scher, H. I.; Rubin, M. A.; Giancotti, F.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Understanding the proteome through the chaperome: From mechanisms to diagnostics and drugs
    Meeting Abstract

    Chiosis, G.
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Predictive biomarkers of tumor sensitivity to STEAP1 antibody-drug conjugate (ADC) in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC)
    Meeting Abstract

    Danila, D. C.; Scher, H. I.; Szafer-Glusman, E.; Herkal, A.; Suttmann, R.; Fleisher, M.; Schreiber, N. A.; Curtis, K.; Gilbert, H.; Maslyar, D.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Epigenetic loss-of-function BRCA1 mediates tumor cure by single dose radiotherapy
    Meeting Abstract

    Campagne, C. G.; Thin, T. H.; Fuller, J. D.; Ackerstaff, E.; Koutcher, J. A.; Haimovitz-Friedman, A.; Powell, S. N.; Kolesnick, R. N.; Fuks, Z.
    Cancer Research (2015)

    Fulltext@MSK | Save